Induction of haemoglobin synthesis in the human leukaemia cell line K562 by monomethyltriazenes and imidazotetrazinones
- 1 June 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (12) , 2077-2082
- https://doi.org/10.1016/0006-2952(85)90398-3
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Antitumour imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one, a novel broad-spectrum antitumor agentJournal of Medicinal Chemistry, 1984
- DNA methylation and methylase levels in normal and malignant mouse hepatic tissuesCarcinogenesis: Integrative Cancer Research, 1981
- Studies of the mode of action of antitumour triazenes and triazines—II. Investigation of the selective toxicity of 1-aryl-3,3-dimethyltriazenesBiochemical Pharmacology, 1981
- DNA Methylation and Gene FunctionScience, 1980
- Induction of differentiation in cultured mouse neuroblastoma cells by N-methyl-N′-nitro-N-nitrosoguanidineBiochemical and Biophysical Research Communications, 1979
- Properties of the K562 cell line, derived from a patient with chronic myeloid leukemiaInternational Journal of Cancer, 1976
- Tumour inhibitory triazenes: Structural requirements for an active metaboliteBiochemical Pharmacology, 1976
- Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosomeBlood, 1975
- Studies on the mechanism of action of the tumour inhibitory triazenesBiochemical Pharmacology, 1973
- Mechanism of carcinogenesis with 1-aryl-3,3-dialkyltriazenes—II in vitro-alkylation of guanosine, RNA and DNA with aryl-monoalkyltriazenes to form 7-alkylguanineBiochemical Pharmacology, 1970